14-day Premium Trial Subscription Try For FreeTry Free
$0.0008
+0 (+0%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0007 $0.0023 Friday, 3rd May 2024 PPCB stock ended at $0.0008. During the day the stock fluctuated 14.29% from a day low at $0.0007 to a day high of $0.0008.
90 days $0.0007 $0.0065
52 weeks $0.0001 $0.263

Historical Propanc Biopharma Inc prices

Date Open High Low Close Volume
Mar 28, 2024 $0.0045 $0.0045 $0.0025 $0.0032 11 376 478
Mar 27, 2024 $0.0027 $0.0045 $0.0027 $0.0039 6 470 142
Mar 26, 2024 $0.0028 $0.0028 $0.0022 $0.0027 6 455 552
Mar 25, 2024 $0.0032 $0.0033 $0.0026 $0.0028 2 678 258
Mar 22, 2024 $0.0032 $0.0032 $0.0025 $0.0031 6 532 645
Mar 21, 2024 $0.0029 $0.0030 $0.0029 $0.0030 1 377 314
Mar 20, 2024 $0.0031 $0.0032 $0.0025 $0.0030 1 706 600
Mar 19, 2024 $0.0028 $0.0033 $0.0024 $0.0031 6 270 942
Mar 18, 2024 $0.0038 $0.0038 $0.0028 $0.0029 4 003 730
Mar 15, 2024 $0.0034 $0.0044 $0.0027 $0.0044 8 846 980
Mar 14, 2024 $0.0031 $0.0040 $0.0026 $0.0034 4 969 773
Mar 13, 2024 $0.0039 $0.0039 $0.0027 $0.0027 2 992 425
Mar 12, 2024 $0.0035 $0.0043 $0.0033 $0.0033 740 736
Mar 11, 2024 $0.0041 $0.0041 $0.0036 $0.0040 1 014 149
Mar 08, 2024 $0.0044 $0.0044 $0.0040 $0.0043 1 418 027
Mar 07, 2024 $0.0032 $0.0044 $0.0030 $0.0043 2 066 861
Mar 06, 2024 $0.0027 $0.0030 $0.0024 $0.0030 1 481 909
Mar 05, 2024 $0.0029 $0.0030 $0.0023 $0.0027 2 161 010
Mar 04, 2024 $0.0032 $0.0032 $0.0027 $0.0029 1 774 469
Mar 01, 2024 $0.0034 $0.0034 $0.0027 $0.0032 5 740 106
Feb 29, 2024 $0.0044 $0.0044 $0.0029 $0.0034 2 708 599
Feb 28, 2024 $0.0042 $0.0048 $0.0035 $0.0040 2 959 740
Feb 27, 2024 $0.0040 $0.0044 $0.0034 $0.0040 2 489 870
Feb 26, 2024 $0.0037 $0.0064 $0.0027 $0.0036 2 094 515
Feb 23, 2024 $0.0040 $0.0043 $0.0027 $0.0029 3 980 336
Click to get the best stock tips daily for free!

About Propanc Biopharma Inc

Propanc Biopharma Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc... PPCB Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT